	Predictive value of baseline levels and early dynamic changes of ctDNA for 28-day mortality in ICU patients with advanced lung cancer: a prospective single-center cohort study. Front Mol Biosci Tan L, Lu D, Huang H, Lin D, Zheng D. PMID: 42416486 [PubMed]
	Epithelial and microenvironmental mosaicism under stress: a two-compartment model for lung cancer development in never-smokers. Front Cell Dev Biol Burr R. PMID: 42416117 [PubMed - in process]
	Clinicopathological features and therapeutic advances in primary pulmonary lymphoepithelioma-like carcinoma (Review). Oncol Lett Chen Y, Yu Y, Chen X. PMID: 42416029 [PubMed]
	LungCraft: a hybrid 3D-2D deep learning and radiomics framework with explainable AI for precision diagnosis of lung cancer. Front Artif Intell Kodipyaka N, Suganya G, Johnson DR. PMID: 42415845 [PubMed]
	Efficacy of Jishi Shuanghua Granules in preventing radiation-induced esophagitis in non-small cell lung cancer patients undergoing concurrent chemoradiotherapy: protocol for a multicenter, randomized, double-blind, placebo-controlled trial. Front Med (Lausanne) Li H, Mi Y, Xu K, Fan M, Yin J, Li Q, Wu Z, Gong C, Jia Y, Gu P, Wei S, Zhang Z, Zhang S, Zheng Y, Lin B, Lang J, Zhao B, Chen M. PMID: 42415804 [PubMed - in process]
	Population-Level Trends in Lung Cancer Mortality and Stage Distribution During the USPSTF LDCT Guideline Era: A Multi-Database Quasi-Experimental Study. Cancer Control Xia K, Wang J. PMID: 42415351 [PubMed - in process]
	Automated lung cancer classification using intensity-driven RoI selection and transfer learning. BMC Med Inform Decis Mak Ahmed ST, Satheesha TY, Nagaraja LH, Shankar A, Kumar A, Fathima AS. PMID: 42415103 [PubMed - as supplied by publisher]
	Immune-related adverse event profiles and survival outcomes in non-small cell lung cancer: a cluster analysis from a long-term real-world study. Respir Res Xu Y, Chen Z, Chen H, Liu J, Liu J. PMID: 42415046 [PubMed - as supplied by publisher]
	Associations of lung and bronchus cancer incidence and ambient temperature and severe drought: a population-based study. BMC Public Health Majeed H, Kypriotakis G. PMID: 42414983 [PubMed - as supplied by publisher]
	Prophylactic cranial irradiation in the era of immunotherapy in extensive-stage small cell lung cancer: a systematic review and meta-analysis. Clin Transl Oncol Wróbel D, Rogaczewski P, Ostruszka N, Borowczak J, Bandura A, Potocki PM. PMID: 42414844 [PubMed - as supplied by publisher]
	The effect of cancer response style on anxiety and depression levels in newly diagnosed lung cancer patients. Support Care Cancer Ya, Karada, U, Ata. PMID: 42414557 [PubMed - in process]
	HyCANet: a hybrid convolutional-attention network with cross-attention fusion for lung cancer histopathological classification. Sci Rep Upmanu V, Alleema NN, Saxena P, Singh J, Pandey V, Paliwal S. PMID: 42414443 [PubMed - as supplied by publisher]
	EGFR Mutations and Recurrence Outcomes in Resected Non-Small Cell Lung Cancer: An Updated 2015-2025 Systematic Review and Meta-Analysis. Thorac Cancer Kim SH, Seong H, Jang H, Kim S, Yoo W, Mok J, Lee K, Kim KU, Lee MK, Kim MH, Eom JS. PMID: 42414222 [PubMed - in process]
	Chinese Expert Consensus on Radiotherapy Combined with Immunotherapy for Unresectable Lung Cancer (2026 Edition). Cancer Lett Wang L, Liu Y, Zhao W, Xing L, Hui Z, Liu X, Chen M, Wu Y, Chen L, Zhou C, Yu J, Chairpersons, Vice Chairpersons, Reviewers, Secretaries, Expert Panel Members. PMID: 42413815 [PubMed - as supplied by publisher]
	Study of benign prostatic hyperplasia and androgen pathway manipulation on lung cancer survivals. J Adv Res Lee PH, Cheng PT, Celik A, Lien CY, Oner M, Chen MC, Tseng JS, Huang YH, Hsu YW, Hsu KH, Hsieh JT, Yang TY, Lin H. PMID: 42413655 [PubMed - as supplied by publisher]
	Ifebemtinib plus garsorasib as first-line treatment for KRAS(G12C)-mutated non-small-cell lung cancer in China: a multicentre, single-arm expansion cohort from a phase 1b/2 trial. Lancet Respir Med Song Z, Li X, Lin R, Shi H, Yuan Y, Liu Y, Luo Y, Lv T, Zhang Y, Zhu L, Zhu Y, Zhang L, Wang Z. PMID: 42413526 [PubMed - as supplied by publisher]
	Nanoparticle-based drug delivery for precision lung cancer therapy: Tumor microenvironment modulation and theranostic applications. Lung Cancer Kumar RR, Enoch IV. PMID: 42413210 [PubMed - as supplied by publisher]
	Transportability of tislelizumab trial outcomes from RATIONALE-315, RATIONALE-303, and RATIONALE-312 to the European population in early-stage non-small cell lung cancer (NSCLC), advanced NSCLC and extensive-stage small cell lung cancer (ES-SCLC). Future Oncol Passiglia F, Priedane E, Mardiguian S, Farraia M, Pandey A, Shukla P, Wilamowitz-Moellendorff CV, Rivolo S, Mendoza-Naranjo A, Leaw S, Naicker K, Wang Y, Lin X, Kapetanakis V. PMID: 42412689 [PubMed - as supplied by publisher]
	Retraction: Randomized Trial of Relevance of Time-of-Day of Immunochemotherapy for Progression-free and Overall Survival in Patients With Non-small Cell Lung Cancer. J Clin Oncol Zhang Y, Huang Z, Zeng L, Ruan Z, Zeng Q, Yan H, Jiang W, Dai J, Zou N, Xu S, Deng J, Chen X, Wang J, Xiang H, Li X, Duchemann B, Chen G, Scheiermann C, Yang N, Lévi FA. PMID: 42413071 [PubMed - as supplied by publisher]
	Resection of Primary Lung Tumors in Patients with Stage IV EGFR-Mutant Lung Adenocarcinoma before Progression under First-Line TKI Treatment and Its Impact on Prognosis. Ann Surg Oncol Chang YP, Chen YM, Tsai MY, Lee SH, Lin CY, Wang CC, Lo CM, Chang HC, Chen HC, Chung CF, Lai HH, Chuang KH, Chen Y, Huang KT. PMID: 42412352 [PubMed - as supplied by publisher]

Articles 1 - 20 / 161290

Page 1 of 8065



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy